News

Kanazawa University researchers find similarities in the impeded signalling between central insulin activity and glucose production in the liver for both obese mice and mice that have had the vagus nerve removed.

Nanotechnology-based delivery system developed to control a variety of skin pathologies and disorders.

Company has announced collaboration with DNA Software Inc. to develop high-multiplex infectious disease panels for commercialization on InSilixa’s CMOS biochip platform.

Company has announced that the USPTO has issued U.S. patent for improving data quality and small RNA sequencing technology.

Company has announced that it has secured EUR 24 million to the development of its proprietary TriMix mRNA-based immunotherapies for melanoma, breast cancer and infectious diseases.

Fundraise will support commercial expansion and translational product development.

Innovative software tools allowed the scientists to construct accurate "maps" of gene networks for about 400 different human cell and tissue types, ranging from immune cells to brain tissues, whereas previous studies were limited to just one or few tissues.

In the ongoing arms race between pathogenic viruses and the cells they infect, each side needs every advantage it can get. One way wily viruses can get a leg up is by subverting the microRNAs (miRNAs) of their host.

Pledges sizeable investment to collect, sequence, and share critical data to unlock true potential of the human genome, breaking the hoarding data mold that hinders medical progress.

Researchers have reported that photoimmunotherapy is effective against elusive gastric cancer cells following transduction with the gene that expresses the extracellular domain protein of HER2.